NCT00405925View on ClinicalTrials.gov

FREE Study: Efficacy and Toxicity of Trizivir

PHASE3CompletedINTERVENTIONAL
Enrollment

207

Participants

Timeline

Start Date

March 31, 2003

Primary Completion Date

August 31, 2009

Study Completion Date

September 30, 2009

Conditions
HIV Infections
Interventions
DRUG

Trizivir

DRUG

zidovudine,lamivudine,abacavir

zidovudine 300 mg bid, lamivudine 150mg bid, abacavir 300mg bid

Trial Locations (1)

6800 TA

Rijnstate Hospital, Arnhem

Sponsors

Collaborators (1)

GlaxoSmithKline
All Listed Sponsors
collaborator

GlaxoSmithKline

INDUSTRY

lead

Rijnstate Hospital

OTHER